Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity. [electronic resource]
Producer: 20171128Description: 1583-1589 p. digitalISSN:- 1097-4644
- Aniline Compounds -- pharmacology
- Antimetabolites, Antineoplastic -- pharmacology
- Benzodiazepinones -- pharmacology
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cytarabine -- pharmacology
- Gene Expression Regulation, Leukemic -- drug effects
- HL-60 Cells
- Humans
- Indoles -- pharmacology
- Leukemia, Myeloid, Acute -- drug therapy
- Mitogen-Activated Protein Kinase 7 -- antagonists & inhibitors
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.